AGM/EGMMay 29, 2026, 09:03 AM
Traws Pharma Schedules 2026 Annual Meeting for July 8
AI Summary
Traws Pharma, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on July 8, 2026. Stockholders will vote on several key proposals, including the election of seven directors, an amendment to the 2021 Incentive Compensation Plan to increase available shares by 2,000,000, and the ratification of KPMG LLP as the independent auditor. Additionally, stockholders will consider approving the issuance of common stock upon the exercise of Series B and Series C Warrants. The Board of Directors recommends voting "For" all proposals.
Key Highlights
- Annual Meeting of Stockholders to be held virtually on July 8, 2026, at 9:00 a.m. Eastern Time.
- Stockholders will vote to elect seven directors to hold office until the 2027 Annual Meeting.
- Proposal to amend the 2021 Incentive Compensation Plan to increase shares by 2,000,000.
- Proposal to ratify KPMG LLP as independent registered public accounting firm for fiscal year 2026.
- Proposal to approve issuance of common stock upon exercise of Series B and Series C Warrants.
- Board recommends voting "For" all director nominees and "For" all other proposals.
- Record date for voting eligibility is May 18, 2026.
- Proxy materials were made available electronically on or about May 29, 2026.
Price Impact
More from TRAW